Ina Schuppe Koistinen

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2024;:1-9

Plasma bile acids in association with Crohn's disease.

Kiasat A; Prast-Nielsen S; Rautiainen S; Engstrand L; Andersson F; Lindberg J; Schuppe-Koistinen I; Löf Granström A; Gustafsson UO
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023;58(11):1246-1252

Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.

Kiasat A; Rautiainen S; Prast-Nielsen S; Engstrand L; Schuppe-Koistinen I; Gustafsson UO; Löf Granström A
Article: JOURNAL OF CROHNS & COLITIS. 2023;17(3):418-432

Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers.

Nyström N; Prast-Nielsen S; Correia M; Globisch D; Engstrand L; Schuppe-Koistinen I; Halfvarson J
Article: BMC PREGNANCY AND CHILDBIRTH. 2023;23(1):153

Pre-pregnancy complications - associated factors and wellbeing in early pregnancy: a Swedish cohort study.

Gudnadottir U; Du J; Hugerth LW; Engstrand L; Schuppe-Koistinen I; Wiberg Itzel E; Fransson E; Brusselaers N
Article: JOURNAL OF MEDICINAL FOOD. 2023;26(3):185-192

Effects of Consuming Fermented Fish (Surströmming) on the Fecal Microflora in Healthy Individuals.

Kallner A; Debelius J; Schuppe-Koistinen I; Pereira M; Engstrand L
Article: COMMUNICATIONS BIOLOGY. 2023;6(1):20

High-fat diet and estrogen modulate the gut microbiota in a sex-dependent manner in mice.

Hases L; Stepanauskaite L; Birgersson M; Brusselaers N; Schuppe-Koistinen I; Archer A; Engstrand L; Williams C
Article: BMJ OPEN. 2022;12(10):e065825

Cohort profile: the Swedish Maternal Microbiome project (SweMaMi) - assessing the dynamic associations between the microbiome and maternal and neonatal adverse events.

Fransson E; Gudnadottir U; Hugerth LW; Itzel EW; Hamsten M; Boulund F; Pennhag A; Du J; Schuppe-Koistinen I; Brusselaers N; Engstrand L
Article: HUMAN REPRODUCTION. 2022;37(7):1525-1543

The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle.

Krog MC; Hugerth LW; Fransson E; Bashir Z; Nyboe Andersen A; Edfeldt G; Engstrand L; Schuppe-Koistinen I; Nielsen HS
Article: SCIENTIFIC REPORTS. 2022;12(1):7926

The vaginal microbiome and the risk of preterm birth: a systematic review and network meta-analysis.

Gudnadottir U; Debelius JW; Du J; Hugerth LW; Danielsson H; Schuppe-Koistinen I; Fransson E; Brusselaers N
Article: NPJ BIOFILMS AND MICROBIOMES. 2022;8(1):34

The right bug in the right place: opportunities for bacterial vaginosis treatment.

Wu S; Hugerth LW; Schuppe-Koistinen I; Du J
Article: MSYSTEMS. 2021;6(3):e00175-e00121

A MicroRNA Gene Panel Predicts the Vaginal Microbiota Composition.

Cheng L; Kaźmierczak D; Norenhag J; Hamsten M; Fransson E; Schuppe-Koistinen I; Olovsson M; Engstrand L; Hydbring P; Du J
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2021;224(3):296.e1-296.e23

No evidence for a placental microbiome in human pregnancies at term.

Sterpu I; Fransson E; Hugerth LW; Du J; Pereira M; Cheng L; Radu SA; Calderón-Pérez L; Zha Y; Angelidou P; Pennhag A; Boulund F; Scheynius A; Engstrand L; Wiberg-Itzel E; Schuppe-Koistinen I
Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021;11:625229

Dysbiosis of the Human Oral Microbiome During the Menstrual Cycle and Vulnerability to the External Exposures of Smoking and Dietary Sugar.

Bostanci N; Krog MC; Hugerth LW; Bashir Z; Fransson E; Boulund F; Belibasakis GN; Wannerberger K; Engstrand L; Nielsen HS; Schuppe-Koistinen I
Article: MSPHERE. 2020;5(6):e00448-e00420

Assessment of In Vitro and In Silico Protocols for Sequence-Based Characterization of the Human Vaginal Microbiome.

Hugerth LW; Pereira M; Zha Y; Seifert M; Kaldhusdal V; Boulund F; Krog MC; Bashir Z; Hamsten M; Fransson E; Svarre-Nielsen H; Schuppe-Koistinen I; Engstrand L
Article: NPJ BIOFILMS AND MICROBIOMES. 2020;6(1):39

Vaginal microbiota and human papillomavirus infection among young Swedish women.

Cheng L; Norenhag J; Hu YOO; Brusselaers N; Fransson E; Ährlund-Richter A; Guðnadóttir U; Angelidou P; Zha Y; Hamsten M; Schuppe-Koistinen I; Olovsson M; Engstrand L; Du J
Article: NATURE COMMUNICATIONS. 2020;11(1):4487

Integration of molecular profiles in a longitudinal wellness profiling cohort.

Tebani A; Gummesson A; Zhong W; Koistinen IS; Lakshmikanth T; Olsson LM; Boulund F; Neiman M; Stenlund H; Hellström C; Karlsson MJ; Arif M; Dodig-Crnković T; Mardinoglu A; Lee S; Zhang C; Chen Y; Olin A; Mikes J; Danielsson H; von Feilitzen K; Jansson P-A; Angerås O; Huss M; Kjellqvist S; Odeberg J; Edfors F; Tremaroli V; Forsström B; Schwenk JM; Nilsson P; Moritz T; Bäckhed F; Engstrand L; Brodin P; Bergström G; Uhlen M; Fagerberg L
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(8):1014-1021

Risk factors for poor neonatal outcome in pregnancies with decreased fetal movements.

Sterpu I; Pilo C; Koistinen IS; Lindqvist PG; Gemzell-Danielsson K; Itzel EW
Article: EBIOMEDICINE. 2020;57:102854

Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling.

Dodig-Crnković T; Hong M-G; Thomas CE; Häussler RS; Bendes A; Dale M; Edfors F; Forsström B; Magnusson PKE; Schuppe-Koistinen I; Odeberg J; Fagerberg L; Gummesson A; Bergström G; Uhlén M; Schwenk JM
Article: HEPATOLOGY. 2019;69(2):760-773

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.

Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer J-M; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
Article: AUTOIMMUNITY. 2019;52(1):1-11

Individual and stable autoantibody repertoires in healthy individuals.

Neiman M; Hellström C; Just D; Mattsson C; Fagerberg L; Schuppe-Koistinen I; Gummesson A; Bergström G; Kallioniemi O; Achour A; Sallinen R; Uhlén M; Nilsson P
Article: BIOMARKERS. 2017;22(5):461-469

A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat.

Thulin P; Hornby RJ; Auli M; Nordahl G; Antoine DJ; Starkey Lewis P; Goldring CE; Park BK; Prats N; Glinghammar B; Schuppe-Koistinen I
Article: OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY. 2017;21(4):207-216

Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.

Petros Z; Lee MTM; Takahashi A; Zhang Y; Yimer G; Habtewold A; Schuppe-Koistinen I; Mushiroda T; Makonnen E; Kubo M; Aklillu E
Article: LIVER INTERNATIONAL. 2017;37(1):132-140

Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.

Mikus M; Drobin K; Gry M; Bachmann J; Lindberg J; Yimer G; Aklillu E; Makonnen E; Aderaye G; Roach J; Fier I; Kampf C; Göpfert J; Perazzo H; Poynard T; Stephens C; Andrade RJ; Lucena MI; Arber N; Uhlén M; Watkins PB; Schwenk JM; Nilsson P; Schuppe-Koistinen I
Article: PLOS ONE. 2017;12(12):e0189436

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.

Peta V; Tse C; Perazzo H; Munteanu M; Ngo Y; Ngo A; Ramanujam N; Verglas L; Mallet M; Ratziu V; Thabut D; Rudler M; Thibault V; Schuppe-Koistinen I; Bonnefont-Rousselot D; Hainque B; Imbert-Bismut F; Merz M; Kullak-Ublick G; Andrade R; van Boemmel F; Schott E; Poynard T; Drug Induced Liver Injury- Groupe Hospitalier Piti; Drug Induced Liver Group of the Injury Safer and F
Article: PSYCHIATRY RESEARCH. 2017;247:105-112

Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.

Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
Article: BMC GENOMICS. 2016;17(1):755

Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.

Petros Z; Lee M-TM; Takahashi A; Zhang Y; Yimer G; Habtewold A; Amogne W; Aderaye G; Schuppe-Koistinen I; Mushiroda T; Makonnen E; Kubo M; Aklillu E
Article: JOURNAL OF NEUROINFLAMMATION. 2016;13(1):51

Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.

Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
Article: SCIENTIFIC REPORTS. 2015;5:16423

Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome.

Eakins R; Walsh J; Randle L; Jenkins RE; Schuppe-Koistinen I; Rowe C; Starkey Lewis P; Vasieva O; Prats N; Brillant N; Auli M; Bayliss M; Webb S; Rees JA; Kitteringham NR; Goldring CE; Park BK
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2015;40(2):126-133

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

Schwieler L; Larsson MK; Skogh E; Kegel ME; Orhan F; Abdelmoaty S; Finn A; Bhat M; Samuelsson M; Lundberg K; Dahl M-L; Sellgren C; Schuppe-Koistinen I; Svensson C; Erhardt S; Engberg G
Article: CELL. 2014;159(1):33-45

Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression.

Agudelo LZ; Femenía T; Orhan F; Porsmyr-Palmertz M; Goiny M; Martinez-Redondo V; Correia JC; Izadi M; Bhat M; Schuppe-Koistinen I; Pettersson AT; Ferreira DMS; Krook A; Barres R; Zierath JR; Erhardt S; Lindskog M; Ruas JL
Article: LIVER INTERNATIONAL. 2014;34(3):367-378

Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.

Thulin P; Nordahl G; Gry M; Yimer G; Aklillu E; Makonnen E; Aderaye G; Lindquist L; Mattsson CM; Ekblom B; Antoine DJ; Park BK; Linder S; Harrill AH; Watkins PB; Glinghammar B; Schuppe-Koistinen I
Article: INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH. 2014;7:15-22

Imbalanced kynurenine pathway in schizophrenia.

Kegel ME; Bhat M; Skogh E; Samuelsson M; Lundberg K; Dahl M-L; Sellgren C; Schwieler L; Engberg G; Schuppe-Koistinen I; Erhardt S
Article: PLOS ONE. 2014;9(4):e94271

Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.

Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
Article: BIOMED RESEARCH INTERNATIONAL. 2013;2013:202497-12

Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Mattes WB; Kamp HG; Fabian E; Herold M; Krennrich G; Looser R; Mellert W; Prokoudine A; Strauss V; van Ravenzwaay B; Walk T; Naraoka H; Omura K; Schuppe-Koistinen I; Nadanaciva S; Bush ED; Moeller N; Ruiz-Noppinger P; Piccoli SP
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2012;30(5):1241-1249

Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans.

Rafter I; Gråberg T; Kotronen A; Strömmer L; Mattson CM; Kim RW; Ehrenborg E; Andersson HB; Yki-Järvinen H; Schuppe-Koistinen I; Ekblom B; Cotgreave I; Glinghammar B
Article: TOXICOLOGICAL SCIENCES. 2012;127(1):150-158

The development of in vitro culture methods to characterize primary T-cell responses to drugs.

Faulkner L; Martinsson K; Santoyo-Castelazo A; Cederbrant K; Schuppe-Koistinen I; Powell H; Tugwood J; Naisbitt DJ; Park BK
Article: PLOS ONE. 2012;7(8):e42418

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.

M'Kada H; Perazzo H; Munteanu M; Ngo Y; Ramanujam N; Fautrel B; Imbert-Bismut F; Ratziu V; Schuppe-Koistinen I; Leblond V; Delattre JY; Samson Y; Caen OL; Bricaire F; Khayat D; Pierrot-Deseilligny C; Herson S; Amoura Z; Tilleul P; Deckmyn O; Coriat P; Delpech VN; Boulogne P; Bonnefont-Rousselot D; Poynard T; Drug Induced Liver Injury Groupe Hospitalier Pitié; Safer and Faster Evidence-based Translation Consor
Article: JOURNAL OF PROTEOME RESEARCH. 2011;10(11):4925-4934

Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment.

Neiman M; Hedberg JJ; Dönnes PR; Schuppe-Koistinen I; Hanschke S; Schindler R; Uhlén M; Schwenk JM; Nilsson P
Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2011;60(3):290-295

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI).

M'Kada H; Munteanu M; Perazzo H; Ngo Y; Ramanujam N; Imbert-Bismut F; Ratziu V; Bonnefont-Rousselot D; Souberbielle B; Schuppe-Koistinen I; Poynard T; DILI group of the SAFE-T consortium
Article: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2010;88(2):260-262

A systematic approach to preclinical and clinical safety biomarker qualification incorporating Bradford Hill's principles of causality association.

Chetty RK; Ozer JS; Lanevschi A; Schuppe-Koistinen I; McHale D; Pears JS; Vonderscher J; Sistare FD; Dieterle F
Article: BIOMARKERS. 2010;15(5):424-435

Application of Dolichos biflorus in immunoassay detection of kidney collecting duct biomarkers.

Sourial S; Searchfield L; Schuppe-Koistinen I; Betton GR; Riccardi D; Price SA
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2010;396(5):1681-1689

Time-resolved biomarker discovery in 1H-NMR data using generalized fuzzy Hough transform alignment and parallel factor analysis.

Alm E; Torgrip RJO; Aberg KM; Schuppe-Koistinen I; Lindberg J
Article: BIOMARKERS. 2009;14(8):572-586

A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran.

Andersson U; Lindberg J; Wang S; Balasubramanian R; Marcusson-Ståhl M; Hannula M; Zeng C; Juhasz PJ; Kolmert J; Bäckström J; Nord L; Nilsson K; Martin S; Glinghammar B; Cederbrant K; Schuppe-Koistinen I
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2009;395(1):213-223

A solution to the 1D NMR alignment problem using an extended generalized fuzzy Hough transform and mode support.

Alm E; Torgrip RJO; Aberg KM; Schuppe-Koistinen I; Lindberg J
Article: JOURNAL OF HEPATOLOGY. 2009;50(3):572-583

The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model.

Butura A; Nilsson K; Morgan K; Morgan TR; French SW; Johansson I; Schuppe-Koistinen I; Ingelman-Sundberg M
Article: METABOLOMICS. 2008;4(2):114-121

A note on normalization of biofluid 1D ¹H-NMR data

Torgrip RJO; Aberg KM; Alm E; Schuppe-Koistinen I; Lindberg J
Article: JOURNAL OF CHROMATOGRAPHY A. 2008;1192(1):139-146

Feature detection and alignment of hyphenated chromatographic-mass spectrometric data. Extraction of pure ion chromatograms using Kalman tracking.

Aberg KM; Torgrip RJO; Kolmert J; Schuppe-Koistinen I; Lindberg J
Article: MOLECULAR BIOSYSTEMS. 2008;4(3):249-259

Correlation network analysis for data integration and biomarker selection.

Adourian A; Jennings E; Balasubramanian R; Hines WM; Damian D; Plasterer TN; Clish CB; Stroobant P; McBurney R; Verheij ER; Bobeldijk I; van der Greef J; Lindberg J; Kenne K; Andersson U; Hellmold H; Nilsson K; Salter H; Schuppe-Koistinen I
Article: JOURNAL OF PROTEOME RESEARCH. 2007;6(12):4572-4581

Analysis of time-related metabolic fluctuations induced by ethionine in the rat.

Skordi E; Yap IKS; Claus SP; Martin F-PJ; Cloarec O; Lindberg J; Schuppe-Koistinen I; Holmes E; Nicholson JK
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2007;389(3):875-885

Proof of principle of a generalized fuzzy Hough transform approach to peak alignment of one-dimensional 1H NMR data.

Csenki L; Alm E; Torgrip RJO; Aberg KM; Nord LI; Schuppe-Koistinen I; Lindberg J
Article: METABOLOMICS. 2007;3(3):179-188

Standard reporting requirements for biological samples in metabolomics experiments: mammalian/in vivo experiments

Griffin JL; Nicholls AW; Daykin CA; Heald S; Keun HC; Schuppe-Koistinen I; Griffiths JR; Cheng LL; Rocca-Serra P; Rubtsov DV; Robertson D
Article: METABOLOMICS. 2007;2(4):257-268

Statistical multivariate metabolite profiling for aiding biomarker pattern detection and mechanistic interpretations in GC/MS based metabolomics

Pohjanen E; Thysell E; Lindberg J; Schuppe-Koistinen I; Moritz T; Jonsson P; Antti H
Article: OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY. 2007;11(2):209-224

Reliable profile detection in comparative metabolomics.

Thysell E; Pohjanen E; Lindberg J; Schuppe-Koistinen I; Moritz T; Jonsson P; Antti H
Article: METABOLOMICS. 2006;2(3):135-143

A strategy for modelling dynamic responses in metabolic samples characterized by GC/MS

Jonsson P; Stenlund H; Moritz T; Trygg J; Sjostrom M; Verheij ER; Lindberg J; Schuppe-Koistinen I; Antti H
Article: JOURNAL OF PROTEOME RESEARCH. 2006;5(6):1407-1414

Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis.

Jonsson P; Johansson ES; Wuolikainen A; Lindberg J; Schuppe-Koistinen I; Kusano M; Sjöström M; Trygg J; Moritz T; Antti H
Article: ANALYTICAL CHEMISTRY. 2006;78(4):975-983

Second-order peak detection for multicomponent high-resolution LC/MS data.

Stolt R; Torgrip RJO; Lindberg J; Csenki L; Kolmert J; Schuppe-Koistinen I; Jacobsson SP
Article: METABOLOMICS. 2006;2(1):1-19

New modes of data partitioning based on PARS peak alignment for improved multivariate biomarker/biopattern detection in 1H-NMR spectroscopic metabolic profiling of urine.

Torgrip RJO; Lindberg J; Linder M; Karlberg B; Jacobsson SP; Kolmert J; Gustafsson I; Schuppe-Koistinen I
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;828(1-2):14-20

Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data.

Idborg H; Zamani L; Edlund P-O; Schuppe-Koistinen I; Jacobsson SP
Article: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;828(1-2):9-13

Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry.

Idborg H; Zamani L; Edlund P-O; Schuppe-Koistinen I; Jacobsson SP
Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(7):1249-1258

Differentiation of human hepatoma cells during confluence as revealed by gene expression profiling.

Butura A; Johansson I; Nilsson K; Wärngård L; Ingelman-Sundberg M; Schuppe-Koistinen I
Article: ANALYTICAL CHEMISTRY. 2003;75(18):4784-4792

Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis.

Idborg-Björkman H; Edlund P-O; Kvalheim OM; Schuppe-Koistinen I; Jacobsson SP
Article: BRAIN RESEARCH. 2003;115(2):130-146

Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha.

Franzén B; Duvefelt K; Jonsson C; Engelhardt B; Ottervald J; Wickman M; Yang Y; Schuppe-Koistinen I
Article: ANALYTICA CHIMICA ACTA. 2003;487(2):189-199

Peak alignment of NMR signals by means of a genetic algorithm

Forshed J; Schuppe-Koistinen I; Jacobsson SP
Article: ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2002;406(2):229-240

Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis.

Lind C; Gerdes R; Hamnell Y; Schuppe-Koistinen I; von Löwenhielm HB; Holmgren A; Cotgreave IA
Article: TOXICOLOGY. 2002;179(3):197-219

Molecular profiling of hepatotoxicity induced by a aminoguanidine carboxylate in the rat: gene expression profiling.

Schuppe-Koistinen I; Frisk A-L; Janzon L
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1998;247(2):481-486

Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin.

Lind C; Gerdes R; Schuppe-Koistinen I; Cotgreave IA
Visa fler

Alla övriga publikationer

Letter: CLINICAL AND EXPERIMENTAL ALLERGY. 2023;53(11):1212-1215

The gut microbiome and asthma in a Swedish twin study.

Mubanga M; Ploner A; Schuppe-Koistinen I; Magnusson PKE; Boulund F; Debelius JW; Almqvist C
Review: HUMAN REPRODUCTION OPEN. 2022;2022(2):hoac015

The microbiome in reproductive health: protocol for a systems biology approach using a prospective, observational study design.

Krog MC; Madsen ME; Bliddal S; Bashir Z; Vexø LE; Hartwell D; Hugerth LW; Fransson E; Hamsten M; Boulund F; Wannerberger K; Engstrand L; Schuppe-Koistinen I; Nielsen HS
Corrigendum: MSPHERE. 2020;5(6):e01253-e01220

Erratum for Hugerth et al., "Assessment of In Vitro and In Silico Protocols for Sequence-Based Characterization of the Human Vaginal Microbiome".

Hugerth LW; Pereira M; Zha Y; Seifert M; Kaldhusdal V; Boulund F; Krog MC; Bashir Z; Hamsten M; Fransson E; Nielsen HS; Schuppe-Koistinen I; Engstrand L
Review: REPRODUCTIVE BIOMEDICINE ONLINE. 2020;41(3):443-453

The reproductive microbiome - clinical practice recommendations for fertility specialists.

García-Velasco JA; Budding D; Campe H; Malfertheiner SF; Hamamah S; Santjohanser C; Schuppe-Koistinen I; Nielsen HS; Vieira-Silva S; Laven J
Corrigendum: CELL. 2015;160(1-2):351

Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression (vol 159, pg 33, 2014)

Agudelo LZ; Femenia T; Orhan F; Porsmyr-Palmertz M; Goiny M; Martinez-Redondo V; Correia JC; Izadi M; Bhat M; Schuppe-Koistinen I; Pettersson A; Ferreira DMS; Krook A; Barres R; Zierath JR; Erhardt S; Lindskog M; Ruas JL
Editorial comment: TOXICOLOGICAL SCIENCES. 2012;129(2):249-255

SOT/EUROTOX debate: biomarkers from blood and urine will replace traditional histopathological evaluation to determine adverse responses.

Boekelheide K; Schuppe-Koistinen I
Review: DRUG DISCOVERY TODAY. 2011;16(13-14):600-608

A generic operational strategy to qualify translational safety biomarkers.

Matheis K; Laurie D; Andriamandroso C; Arber N; Badimon L; Benain X; Bendjama K; Clavier I; Colman P; Firat H; Goepfert J; Hall S; Joos T; Kraus S; Kretschmer A; Merz M; Padro T; Planatscher H; Rossi A; Schneiderhan-Marra N; Schuppe-Koistinen I; Thomann P; Vidal J-M; Molac B
Editorial comment: NATURE BIOTECHNOLOGY. 2005;23(7):833-838

Summary recommendations for standardization and reporting of metabolic analyses.

Lindon JC; Nicholson JK; Holmes E; Keun HC; Craig A; Pearce JTM; Bruce SJ; Hardy N; Sansone S-A; Antti H; Jonsson P; Daykin C; Navarange M; Beger RD; Verheij ER; Amberg A; Baunsgaard D; Cantor GH; Lehman-McKeeman L; Earll M; Wold S; Johansson E; Haselden JN; Kramer K; Thomas C; Lindberg J; Schuppe-Koistinen I; Wilson ID; Reily MD; Robertson DG; Senn H; Krotzky A; Kochhar S; Powell J; van der Ouderaa F; Plumb R; Schaefer H; Spraul M; Standard Metabolic Reporting Structures working gr
Published conference paper: TOXICOLOGY LETTERS. 2002;127(1-3):239-243

Identification of end points relevant to detection of potentially adverse drug reactions.

Hellmold H; Nilsson CB; Schuppe-Koistinen I; Kenne K; Wärngård L
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2002;348:175-182

S-glutathionylation of glyceraldehyde-3-phosphate dehydrogenase: role of thiol oxidation and catalysis by glutaredoxin.

Cotgreave IA; Gerdes R; Schuppe-Koistinen I; Lind C
Published conference paper: ATLA-ALTERNATIVES TO LABORATORY ANIMALS. 2001;29(3):287-289

Molecular profiling and prediction of toxicity

Schuppe-Koistinen I

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI